ABVC BioPharma Inc (ABVC) Implied Volatility Current

Tracking ABVC implied volatility helps you identify when options premiums on ABVC BioPharma Inc are historically cheap or expensive, and where the best trades are hiding. ABVC BioPharma Inc implied volatility reflects the market's expectation of future price movement: when ABVC IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor ABVC BioPharma Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ABVC, tracking metrics like ABVC IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ABVC signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for attention deficit hyperactivity disorder; ABV-1703 has completed Phase I clinical trials for the treatment of pancreatic cancer; ABV-1702 has completed Phase I clinical trials to treat myelodysplastic syndromes; ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage.

It has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ABVC implied volatility sits today versus where it has been. Our scanner ranks ABVC BioPharma Inc implied volatility against its historical range, surfaces extremes in ABVC IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether ABVC BioPharma Inc IV is rich or cheap — measure it, then act on it.